Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19812461 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar Degeneration
Condition: Frontotemporal Lobar Degeneration
Intervention: Drug: Memantine

Indicates status has not been verified in more than two years